I’m shopping for shares right now, should I pop GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) into my basket?
When stock markets caught a cold in May, I suggested GlaxoSmithKline would be the perfect pick-me-up for your portfolio. I had faith in Glaxo, but now it stands accused of bribing Chinese doctors and officials to use its medicines and has just posted a double-digit drop in operating profits. Should I still buy it?
If Glaxo is a great British company, it may be time for some national introspection. The pharmaceutical giant was already under investigation by the OFT for allegedly…